Pet Pharm Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	2,833	3,585	1,656	-	-
Market Cap Growth	2.69%	116.51%	-	-	-
Enterprise Value	2,442	3,187	1,535	-	-
Last Close Price	49.50	70.00	39.48	-	-
PE Ratio	107.61	143.47	114.14	-	-
PS Ratio	12.76	16.14	12.67	-	-
PB Ratio	2.37	3.00	2.84	-	-
P/TBV Ratio	2.62	3.32	2.89	-	-
P/FCF Ratio	591.57	748.49	-	-	-
P/OCF Ratio	82.61	104.52	57.32	-	-
EV/Sales Ratio	11.00	14.35	11.75	-	-
EV/EBITDA Ratio	51.16	83.45	78.93	-	-
EV/EBIT Ratio	165.62	216.15	189.22	-	-
EV/FCF Ratio	509.91	665.45	-	-	-
Debt / Equity Ratio	0.09	0.09	0.25	0.12	0.32
Debt / EBITDA Ratio	2.22	2.22	5.45	1.99	4.49
Debt / FCF Ratio	22.17	22.17	-	5.97	-
Net Debt / Equity Ratio	-0.34	-0.34	-0.42	-0.29	0.19
Net Debt / EBITDA Ratio	-10.81	-10.81	-12.55	-6.41	2.72
Net Debt / FCF Ratio	-86.18	-86.18	1.53	-14.89	-0.92
Asset Turnover	0.21	0.21	0.21	0.35	-
Inventory Turnover	7.46	7.46	4.96	6.42	-
Quick Ratio	10.28	10.28	3.01	6.18	1.94
Current Ratio	10.68	10.68	3.16	10.97	5.05
Return on Equity (ROE)	2.80%	2.80%	2.91%	3.34%	-
Return on Assets (ROA)	0.88%	0.88%	0.81%	1.40%	-
Return on Capital Employed (ROCE)	1.10%	1.10%	1.30%	1.70%	-2.80%
Earnings Yield	0.88%	0.70%	0.88%	-	-
FCF Yield	0.17%	0.13%	-9.63%	-	-
Dividend Yield	0.51%	0.36%	0.23%	-	-
Payout Ratio	20.22%	20.22%	55.42%	-	-
Buyback Yield / Dilution	-32.26%	-32.26%	-37.19%	-23.19%	-
Total Shareholder Return	-31.75%	-31.90%	-36.96%	-23.19%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.